Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
AstraZeneca completes transfer of its global rights to Eklira and Duaklir to Covis Pharma 5 January 2022
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
AstraZeneca completes transfer of its global rights to Eklira and Duaklir to Covis Pharma 5 January 2022
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Oncimmune signs further commercial contracts within its ImmunoINSIGHTS pharma services business 21 December 2021
Touchstone Exploration third test confirms commerciality of newly discovered light oil pool at Royston 21 December 2021
GlaxoSmithKline appoints Sir Dave Lewis as Non-Executive Chair Designate of independent Consumer Healthcare company 20 December 2021
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025